The β2 GABAAR subunit is abnormally expressed in an isoform-specific manner and the ratios of β1 and β2 subunit isoforms are altered in the ER in schizophrenia. Western blot analysis of total β2 GABAAR subunit (β2ALL) and individual β2 GABAAR subunit 50 kDa and 48 kDa isoforms (β250 kDa and β248 kDa, respectively), the ratios of β2 GABAAR subunit isoforms to each other, and the ratio of β1:β2 GABAAR subunit and subunit isoform expression in the ER fraction in schizophrenia and comparison subjects. (a) ER fraction-normalized expression of β2ALL, and specifically the β250 kDa GABAAR subunit isoform, is increased in schizophrenia. (b) The ratio of β248 kDa:β2ALL GABAAR subunit fraction-normalized expression is decreased in the ER in schizophrenia. (c) The ratio of β250 kDa:β248 kDa GABAAR subunit fraction-normalized signal intensities is increased in schizophrenia. (d) Representative images of western blots of the β2 GABAAR subunit, VCP and JM4 from the ER fraction from comparison and schizophrenia subjects with the β250 kDa and β248 kDa protein bands indicated. (e) The ratio of β1:β2ALL, and specifically the ratio of β1:β250 kDa GABAAR subunit expression is significantly less in the ER fraction in schizophrenia. Data are expressed as either the signal intensity of protein targets in the ER fraction normalized to VCP as a loading control and JM4 as an ER marker relative to the VCP-normalized signal intensity of the same target in the total homogenate, or expressed as a ratio of normalized signal intensities, for each data point with means±s.e.m. for each group indicated in a, b, c and e. *P<0.05, **P<0.01. COMP, comparison subject; ER, endoplasmic reticulum; GABAAR, γ-aminobutyric acid type A receptor; SCZ, schizophrenia; VCP, valosin-containing protein.